VENROCK ASSOCIATES III LP's Net Worth
-$17.8 Million
Who is VENROCK ASSOCIATES III LP?
VENROCK ASSOCIATES III LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include PHARMOS CORP, IMPERVA INC, Coley Pharmaceutical Group, Inc., RENOVIS INC, VOCERA COMMUNICATIONS, INC., Vitae Pharmaceuticals, Inc, INTARCIA THERAPEUTICS, INC, and SIRNA THERAPEUTICS INC.
SEC CIK
VENROCK ASSOCIATES III LP's CIK is 0001119517
Past Insider Trading and Trends
2014 was VENROCK ASSOCIATES III LP's most active year for acquiring shares with 12 total transactions. VENROCK ASSOCIATES III LP's most active month to acquire stocks was the month of August. 2012 was VENROCK ASSOCIATES III LP's most active year for disposing of shares, totalling 9 transactions. VENROCK ASSOCIATES III LP's most active month to dispose stocks was the month of August. 2014 saw VENROCK ASSOCIATES III LP paying a total of $6,178,664.00 for 2,354,203 shares, this is the most they've acquired in one year. In 2012 VENROCK ASSOCIATES III LP cashed out on 3,946,708 shares for a total of $349,458.20, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PHARMOS CORP No price found
InvestorVENROCK ASSOCIATES III LP owns 193,302 units of Common Stock. In the year 2009 VENROCK ASSOCIATES III LP acquired a total of 371,129 shares in PHARMOS CORP at a cost of $20,040.97.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.99% | 371.13K |
$0.05 | $20,040.97 | 9.67M |
May 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
IMPERVA INC No price found
InvestorVENROCK ASSOCIATES III LP owns 2,131,994 units of Common Stock. In the year 2011 VENROCK ASSOCIATES III LP filed a total of 3 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +1,290.11% | 1.98M |
—
|
—
| 2.13M |
Nov 15
| |||
Form 4
|
∞
| 153.37K |
$18.00 | $2,760,642.00 | 153.37K |
Nov 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Coley Pharmaceutical Group, Inc. No price found
InvestorVENROCK ASSOCIATES III LP owns 2,017,630 units of Common Stock. In the year 2005 VENROCK ASSOCIATES III LP filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.02M |
—
|
—
| 2.02M |
Aug 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
RENOVIS INC No price found
InvestorVENROCK ASSOCIATES III LP owns 1,443,206 units of Common Stock. In the year 2004 VENROCK ASSOCIATES III LP filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +39,679.66% | 1.44M |
—
|
—
| 1.44M |
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
VOCERA COMMUNICATIONS, INC. No price found
InvestorVENROCK ASSOCIATES III LP owns 4,693,001 units of Common Stock. In the year 2012 VENROCK ASSOCIATES III LP filed a total of 4 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -12.92% | -696.17K |
$24.96 | -$349,458.20 | 4.69M |
Nov 19 - Nov 20
| |||
Form 4/A
| +6.11% | 174.98K |
$17.78 | $3,111,144.40 | 3.04M |
Apr 2
| |||
Form 4
|
∞
| 2.99M |
$17.78 |
—
| 2.99M |
Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |